Structure

Physi-Chem Properties

MedChem Properties

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

ADMET: Distribution

ADMET: Metabolism

ADMET: Excretion

ADMET: Toxicity

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC313850

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT5882 Individual Protein Epoxide hydrolase 2 Rattus norvegicus IC50 = 6.0 nM PMID[538265]
NPT862 Individual Protein Epoxide hydratase Homo sapiens EC50 = 0.14 nM PMID[538265]
NPT862 Individual Protein Epoxide hydratase Homo sapiens IC50 = 8.0 nM PMID[538265]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC313850 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.702 Intermediate Similarity NPC126458
0.6761 Remote Similarity NPC181390
0.6689 Remote Similarity NPC79698
0.6433 Remote Similarity NPC194857
0.6433 Remote Similarity NPC32858
0.6433 Remote Similarity NPC473962
0.6267 Remote Similarity NPC476440
0.625 Remote Similarity NPC55529
0.6224 Remote Similarity NPC167336
0.6131 Remote Similarity NPC473661
0.6111 Remote Similarity NPC473418
0.6087 Remote Similarity NPC71140
0.6043 Remote Similarity NPC256452
0.6013 Remote Similarity NPC322433
0.5959 Remote Similarity NPC473498
0.5921 Remote Similarity NPC473573
0.5912 Remote Similarity NPC119326
0.5886 Remote Similarity NPC192533
0.5871 Remote Similarity NPC226143
0.5858 Remote Similarity NPC478040
0.5857 Remote Similarity NPC246757
0.5857 Remote Similarity NPC291070
0.5855 Remote Similarity NPC246904
0.5854 Remote Similarity NPC266425
0.5854 Remote Similarity NPC316104
0.5854 Remote Similarity NPC162417
0.585 Remote Similarity NPC45033
0.5833 Remote Similarity NPC302169
0.5816 Remote Similarity NPC329430
0.5796 Remote Similarity NPC71684
0.5778 Remote Similarity NPC169016
0.5767 Remote Similarity NPC157311
0.5766 Remote Similarity NPC69057
0.5759 Remote Similarity NPC268534
0.5752 Remote Similarity NPC113099
0.5732 Remote Similarity NPC8761
0.5732 Remote Similarity NPC279385
0.5732 Remote Similarity NPC179605
0.5732 Remote Similarity NPC44805
0.5732 Remote Similarity NPC27833
0.5706 Remote Similarity NPC179224
0.5696 Remote Similarity NPC257490
0.5696 Remote Similarity NPC103292
0.5694 Remote Similarity NPC49994
0.5686 Remote Similarity NPC476048
0.5667 Remote Similarity NPC73644
0.5664 Remote Similarity NPC219573
0.5664 Remote Similarity NPC185208
0.5663 Remote Similarity NPC474473
0.5652 Remote Similarity NPC17497
0.5652 Remote Similarity NPC305602
0.5647 Remote Similarity NPC2823
0.5647 Remote Similarity NPC471164
0.5644 Remote Similarity NPC111428
0.5644 Remote Similarity NPC209389
0.5634 Remote Similarity NPC289883
0.5625 Remote Similarity NPC239185
0.5625 Remote Similarity NPC286551
0.5616 Remote Similarity NPC476993
0.561 Remote Similarity NPC472245
0.5608 Remote Similarity NPC275467
0.5605 Remote Similarity NPC220698

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC313850 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7914 Intermediate Similarity NPD4478 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD7733 Phase 2
0.7517 Intermediate Similarity NPD7622 Phase 2
0.7312 Intermediate Similarity NPD7448 Suspended
0.7179 Intermediate Similarity NPD6240 Phase 3
0.7163 Intermediate Similarity NPD1323 Discontinued
0.7019 Intermediate Similarity NPD6611 Clinical (unspecified phase)
0.6977 Remote Similarity NPD7579 Clinical (unspecified phase)
0.6968 Remote Similarity NPD4705 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7254 Discontinued
0.6867 Remote Similarity NPD5653 Discontinued
0.6853 Remote Similarity NPD851 Approved
0.6853 Remote Similarity NPD853 Approved
0.6853 Remote Similarity NPD4674 Clinical (unspecified phase)
0.6828 Remote Similarity NPD3806 Clinical (unspecified phase)
0.6797 Remote Similarity NPD2754 Discontinued
0.6759 Remote Similarity NPD4660 Discontinued
0.6752 Remote Similarity NPD7541 Clinical (unspecified phase)
0.673 Remote Similarity NPD4461 Discontinued
0.6628 Remote Similarity NPD4645 Clinical (unspecified phase)
0.6607 Remote Similarity NPD1999 Phase 3
0.6607 Remote Similarity NPD2000 Phase 3
0.6594 Remote Similarity NPD813 Approved
0.6577 Remote Similarity NPD5836 Discontinued
0.6575 Remote Similarity NPD1025 Discontinued
0.6566 Remote Similarity NPD8001 Phase 3
0.65 Remote Similarity NPD2980 Phase 2
0.6494 Remote Similarity NPD2413 Phase 2
0.6488 Remote Similarity NPD7744 Clinical (unspecified phase)
0.6481 Remote Similarity NPD3482 Approved
0.6481 Remote Similarity NPD6768 Approved
0.6478 Remote Similarity NPD7192 Discontinued
0.6478 Remote Similarity NPD5227 Clinical (unspecified phase)
0.6474 Remote Similarity NPD3850 Clinical (unspecified phase)
0.6467 Remote Similarity NPD1727 Approved
0.645 Remote Similarity NPD4042 Phase 2
0.645 Remote Similarity NPD4045 Phase 2
0.645 Remote Similarity NPD4507 Discontinued
0.6438 Remote Similarity NPD4077 Clinical (unspecified phase)
0.6438 Remote Similarity NPD6358 Phase 2
0.6433 Remote Similarity NPD6075 Approved
0.6433 Remote Similarity NPD6076 Approved
0.6429 Remote Similarity NPD1387 Phase 1
0.6419 Remote Similarity NPD7679 Phase 2
0.641 Remote Similarity NPD2918 Clinical (unspecified phase)
0.641 Remote Similarity NPD2919 Clinical (unspecified phase)
0.6409 Remote Similarity NPD8069 Phase 3
0.6407 Remote Similarity NPD1890 Clinical (unspecified phase)
0.6405 Remote Similarity NPD3550 Clinical (unspecified phase)
0.6405 Remote Similarity NPD3547 Approved
0.6405 Remote Similarity NPD3549 Approved
0.6402 Remote Similarity NPD4043 Approved
0.6402 Remote Similarity NPD4046 Approved
0.6402 Remote Similarity NPD3481 Approved
0.64 Remote Similarity NPD6839 Clinical (unspecified phase)
0.64 Remote Similarity NPD1217 Clinical (unspecified phase)
0.6392 Remote Similarity NPD6740 Clinical (unspecified phase)
0.6375 Remote Similarity NPD5004 Approved
0.6375 Remote Similarity NPD6817 Clinical (unspecified phase)
0.6369 Remote Similarity NPD8362 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6792 Phase 3
0.6364 Remote Similarity NPD2634 Clinical (unspecified phase)
0.6358 Remote Similarity NPD6806 Phase 1
0.6357 Remote Similarity NPD1386 Phase 1
0.6348 Remote Similarity NPD2461 Phase 1
0.6346 Remote Similarity NPD4549 Discontinued
0.6346 Remote Similarity NPD2909 Phase 3
0.6346 Remote Similarity NPD2908 Phase 3
0.634 Remote Similarity NPD6041 Phase 1
0.634 Remote Similarity NPD3355 Approved
0.634 Remote Similarity NPD3356 Approved
0.6338 Remote Similarity NPD1765 Approved
0.6338 Remote Similarity NPD1767 Approved
0.6338 Remote Similarity NPD1763 Approved
0.6338 Remote Similarity NPD1761 Approved
0.6338 Remote Similarity NPD1766 Approved
0.6323 Remote Similarity NPD1321 Clinical (unspecified phase)
0.6323 Remote Similarity NPD3244 Pre-registration
0.6323 Remote Similarity NPD3245 Phase 3
0.6319 Remote Similarity NPD2010 Phase 3
0.6319 Remote Similarity NPD1222 Discontinued
0.6316 Remote Similarity NPD1124 Approved
0.6316 Remote Similarity NPD1123 Approved
0.6313 Remote Similarity NPD5480 Clinical (unspecified phase)
0.6307 Remote Similarity NPD6786 Discontinued
0.6289 Remote Similarity NPD441 Approved
0.6286 Remote Similarity NPD1795 Discontinued
0.6277 Remote Similarity NPD5554 Approved
0.6275 Remote Similarity NPD3624 Phase 2
0.6271 Remote Similarity NPD3305 Discontinued
0.6265 Remote Similarity NPD7602 Clinical (unspecified phase)
0.6265 Remote Similarity NPD8239 Clinical (unspecified phase)
0.6258 Remote Similarity NPD2056 Discontinued
0.6241 Remote Similarity NPD2648 Phase 3
0.6241 Remote Similarity NPD2193 Phase 2
0.6241 Remote Similarity NPD2171 Approved
0.6236 Remote Similarity NPD6193 Clinical (unspecified phase)
0.6235 Remote Similarity NPD4214 Discontinued
0.6235 Remote Similarity NPD6342 Discontinued
0.6235 Remote Similarity NPD7745 Clinical (unspecified phase)
0.623 Remote Similarity NPD7190 Clinical (unspecified phase)
0.6226 Remote Similarity NPD2846 Clinical (unspecified phase)
0.622 Remote Similarity NPD3434 Clinical (unspecified phase)
0.6214 Remote Similarity NPD1796 Phase 3
0.6214 Remote Similarity NPD4737 Phase 2
0.6196 Remote Similarity NPD4158 Clinical (unspecified phase)
0.6196 Remote Similarity NPD8241 Phase 2
0.619 Remote Similarity NPD8165 Discontinued
0.619 Remote Similarity NPD7088 Discontinued
0.6188 Remote Similarity NPD5840 Discontinued
0.6188 Remote Similarity NPD4503 Phase 2
0.6188 Remote Similarity NPD4680 Discontinued
0.6182 Remote Similarity NPD6566 Discontinued
0.6174 Remote Similarity NPD2508 Discontinued
0.6174 Remote Similarity NPD3551 Approved
0.617 Remote Similarity NPD5630 Phase 1
0.6168 Remote Similarity NPD7575 Phase 3
0.6154 Remote Similarity NPD2962 Approved
0.6154 Remote Similarity NPD2577 Clinical (unspecified phase)
0.6154 Remote Similarity NPD1482 Clinical (unspecified phase)
0.6154 Remote Similarity NPD2961 Approved
0.6139 Remote Similarity NPD1050 Approved
0.6139 Remote Similarity NPD1781 Discontinued
0.6127 Remote Similarity NPD2196 Discontinued
0.6127 Remote Similarity NPD4803 Discontinued
0.6125 Remote Similarity NPD5581 Approved
0.6124 Remote Similarity NPD5921 Clinical (unspecified phase)
0.6121 Remote Similarity NPD7720 Phase 2
0.6114 Remote Similarity NPD5992 Approved
0.6111 Remote Similarity NPD5780 Phase 2
0.6111 Remote Similarity NPD1677 Discontinued
0.6111 Remote Similarity NPD7854 Phase 2
0.6108 Remote Similarity NPD5918 Discontinued
0.6108 Remote Similarity NPD7949 Clinical (unspecified phase)
0.6099 Remote Similarity NPD787 Suspended
0.6095 Remote Similarity NPD6631 Clinical (unspecified phase)
0.6093 Remote Similarity NPD5162 Approved
0.6092 Remote Similarity NPD5660 Approved
0.6092 Remote Similarity NPD5659 Approved
0.6092 Remote Similarity NPD6018 Approved
0.6092 Remote Similarity NPD6019 Approved
0.609 Remote Similarity NPD9541 Approved
0.609 Remote Similarity NPD1640 Clinical (unspecified phase)
0.609 Remote Similarity NPD9539 Approved
0.6087 Remote Similarity NPD1966 Approved
0.6078 Remote Similarity NPD5516 Phase 2
0.6078 Remote Similarity NPD5517 Phase 2
0.6069 Remote Similarity NPD7072 Phase 2
0.6067 Remote Similarity NPD2319 Discontinued
0.6062 Remote Similarity NPD7995 Phase 2
0.6059 Remote Similarity NPD4939 Clinical (unspecified phase)
0.6054 Remote Similarity NPD3581 Discontinued
0.6053 Remote Similarity NPD5991 Approved
0.6053 Remote Similarity NPD7786 Discontinued
0.6053 Remote Similarity NPD5990 Approved
0.6048 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6048 Remote Similarity NPD3508 Approved
0.6042 Remote Similarity NPD4937 Approved
0.6042 Remote Similarity NPD4936 Approved
0.6026 Remote Similarity NPD6408 Phase 1
0.6014 Remote Similarity NPD6588 Clinical (unspecified phase)
0.6013 Remote Similarity NPD6563 Approved
0.6013 Remote Similarity NPD6565 Approved
0.6013 Remote Similarity NPD6564 Approved
0.6013 Remote Similarity NPD9540 Approved
0.6013 Remote Similarity NPD474 Approved
0.6012 Remote Similarity NPD2331 Discontinued
0.6012 Remote Similarity NPD7612 Clinical (unspecified phase)
0.6011 Remote Similarity NPD7065 Clinical (unspecified phase)
0.6 Remote Similarity NPD2192 Approved
0.6 Remote Similarity NPD6655 Clinical (unspecified phase)
0.6 Remote Similarity NPD2197 Approved
0.6 Remote Similarity NPD5187 Clinical (unspecified phase)
0.6 Remote Similarity NPD6998 Discontinued
0.5988 Remote Similarity NPD6639 Clinical (unspecified phase)
0.5985 Remote Similarity NPD5915 Approved
0.5985 Remote Similarity NPD2811 Clinical (unspecified phase)
0.5977 Remote Similarity NPD7267 Clinical (unspecified phase)
0.5976 Remote Similarity NPD8125 Discontinued
0.5976 Remote Similarity NPD6552 Clinical (unspecified phase)
0.5969 Remote Similarity NPD6200 Clinical (unspecified phase)
0.5966 Remote Similarity NPD4393 Approved
0.5966 Remote Similarity NPD33 Approved
0.5965 Remote Similarity NPD4942 Approved
0.5963 Remote Similarity NPD4497 Clinical (unspecified phase)
0.5963 Remote Similarity NPD486 Clinical (unspecified phase)
0.5959 Remote Similarity NPD6834 Approved
0.5944 Remote Similarity NPD1916 Discontinued
0.5941 Remote Similarity NPD3510 Approved
0.5941 Remote Similarity NPD6884 Clinical (unspecified phase)
0.5941 Remote Similarity NPD3509 Approved
0.5939 Remote Similarity NPD6294 Approved
0.5939 Remote Similarity NPD6295 Approved
0.5939 Remote Similarity NPD3934 Clinical (unspecified phase)
0.5938 Remote Similarity NPD4342 Phase 2
0.5938 Remote Similarity NPD7828 Discontinued
0.5938 Remote Similarity NPD5442 Approved
0.5935 Remote Similarity NPD1104 Approved
0.5926 Remote Similarity NPD6632 Clinical (unspecified phase)
0.592 Remote Similarity NPD2790 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data